LEVECETAM

This brand name is authorized in Australia, Ecuador.

Active ingredients

The drug LEVECETAM contains one active pharmaceutical ingredient (API):

1	Levetiracetam UNII 44YRR34555 - LEVETIRACETAM
	Levetiracetam, is a pyrrolidone derivative, chemically unrelated to existing antiepileptic active substances. Levetiracetam induces seizure protection in a broad range of animal models of partial and primary generalised seizures without having a pro-convulsant effect. The primary metabolite is inactive.
	Read more about Levetiracetam

Medication package inserts

Below package inserts are available for further reading:

Document	Type	Information Source
LEVECETAM Film-coated tablet	MPI, EU: SmPC	Pharmaceutical Benefits Scheme (AU)

Medicine classification

This drug has been classified in the anatomical therapeutic chemical (ATC) classification system as follows:

ATC Group		Classification
N03AX14	Levetiracetam	N Nervous system → N03 Antiepileptics → N03A Antiepileptics → N03AX Other antiepileptics
Discover more medicines within N03AX14

Authorization and marketing

This drug has been assigned below unique identifiers within the countries it is being marketed:

Country	Identification scheme	Identifier(s)
AU	Pharmaceutical Benefits Scheme	8654L, 8655M, 8656N
EC	Agencia Nacional de Regulación, Control y Vigilancia Sanitaria	5214-MEE-0720, 5215-MEE-0720